Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- gad-20150221 importedOn "2015-02-21" NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion wasGeneratedBy ECO_0000203 NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion wasDerivedFrom gad-20150221 NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion SIO_000772 16317430 NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion evidence source_evidence_literature NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.
- NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_assertion description "[Testing for TS and GSTP1 polymorphisms may allow identification of gastric cancer patients who will benefit from 5-FU/cisplatin chemotherapy, sparing others the side effects of this chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP50688.RA3Bm_h1iXuil5PMfoV_Qu2qNz9A5iMW_YTF-uYzF6hcg130_provenance.